Nicholas Hall’s OTC.NewDirections is an e-newsletter produced in association with Jenson R+ delivered weekly and includes an inspired mix of global consumer healthcare news and commentary from the viewpoint of the self-care industry, backed by insights from industry experts.

Headlines

1

VITAMIN D: DEFICIENCY LINKED TO DEPRESSION RISK |

IRELAND: Vitamin D deficiency may increase the risk of developing depression later in life, a Trinity College Dublin and St James’s Hospital study concludes. As reported in The Journal of Post-Acute & Long-Term Care Medicine (JAMDA, 20 November), researchers analysed baseline vitamin D levels in relation to depression four years later among 3,965 older participants who were depression-free at baseline ... 

read more >>

2

VITAMIN D: DEFICIENCY AT BIRTH MAY INCREASE SCHIZOPHRENIA RISK |

AUSTRALIA / DENMARK: Vitamin D-deficient newborns may have an increased risk of schizophrenia later in life, according to research in Scientific Reports (6 December). The University of Queensland-led study analysed vitamin D levels in blood samples taken from 1,301 newborns (1981-2000) who later developed schizophrenia ... 

read more >>

3

RESEARCHERS DEVELOP ANAEMIA-DETECTING APP |

USA: Researchers from Georgia Institute of Technology and Emory University have developed a smartphone app that can detect anaemia by a non-invasive procedure, which they introduce as “a paradigm of completely non-invasive, on-demand diagnostics that may replace common blood-based laboratory tests ... 

read more >>

OTC.NewDirections provides you with the latest developments in a number of key areas:

New Ingredients

New Ingredients

Trademarked or patented ingredients & molecules, licensing opportunities and brands seeking partners

New
Products

New Products

Important launches, line extensions & adjacencies (registered OTCs and supplements) with innovative formulations, claims or indications – includes stand-out contributions from our sister service, OTC New Products Tracker

Innovation

Innovation

Technological and scientific advancements, delivery methods, early-stage developments

Medical Devices

Medical Devices

Substance-based devices, mechanical devices, diagnostics

Medical Research

Medical Research

Scientific studies, clinical trials

Switch

Switch

Rx-to-OTC switch, reverse switch, access to medicines

Digital
Health

Digital Health

Mobile & Web apps, wearables, internet connected devices, telehealth

Agency
News

Agency News

Approvals, collaborations, regulatory affairs, guidance

Health Claims & Safety

Health Claims & Safety

New or additional claims approved for specific ingredients or products, disallowed advertising claims, plus alerts and warnings

Cannabis

Cannabis

Key regulatory developments and product launches as this new category evolves in specific markets

E-cigarettes

E-cigarettes

Scientific research, opinion, product development, regulation

In Focus

In Focus

Spotlight on a specific topic

Why subscribe to OTC.NewDirections

1.

Extensive coverage of the World’s innovation, scientific and regulatory environment

2.

Written in collaboration with Jenson R+ and supported by commentary from industry specialists

3.

Quick access to the most important developments

OTC.NewDirections covers all major regions providing you with the essential information to keep you informed of the latest developments affecting your business.

The website also provides you with the opportunity to take a deeper look at trends via the news archive, Supplements Focus and Switch List.

Prepared by our expert team:

Nicola Watts

Nicola Watts
Editor
OTC.NewDirections

Nina Stimpson

Nina Stimson
VP & Consulting Editor
OTC.NewDirections

Kristen McEwan

Kristen McEwan
Assistant Editor
OTC.NewDirections

  • Delivered direct to your inbox every Tuesday, bringing you the latest breaking news and commentary in a concise and easy to read format.
  • Go direct to further information:
    • - clinical trial results
    • - regulatory documents and reports that are of interest to your business.
  • Access our archive of 11,000 stories reaching back to 2012
  • Access the Extras: Supplements Focus and the Switch List